Ir para o conteúdo principal

Infelizmente, não oferecemos suporte total ao seu navegador. Se for possível, atualize para uma versão mais recente ou use o Mozilla Firefox, o Microsoft Edge, o Google Chrome ou o Safari 14 ou mais recente. Se não conseguir e precisar de suporte, envie seu feedback.

Gostaríamos de receber seu feedback sobre essa nova experiência.Diga-nos sua opinião

Elsevier
Publique conosco

Committee & Speakers

Conference Chairs

Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany

Fen-Biao Gao, University of Massachusetts Chan Medical School, USA

Aaron Gitler, University of Stanford, USA

Speakers

Keynote

Victor Ambros

Victor Ambros

University of Massachusetts Chan Medical School, USA

Ler mais sobre Victor Ambros

Session 1: Dysregulated RNA metabolism in neurological diseases

PF

Pietro Fratta

University of College London, UK

LT

Leslie Thompson

University of California, Irvine, USA

Session 2: Physiological functions of disease-linked RNA-binding proteins

JR

Joel Richter

University of Massachusetts Chan Medical School, USA

Gene Yeo

Gene Yeo

University of California, San Diego, USA

Ler mais sobre Gene Yeo

Session 3: Biomolecular condensates and their role in normal RNA processing and in disease

Simon Alberti

Simon Alberti

Dresden University of Technology, Germany

Ler mais sobre Simon Alberti
Roy Parker

Roy Parker

University of Colorado, Boulder, USA

Ler mais sobre Roy Parker

Session 4: Human genetics and genomics insights into neurological diseases

DC

Don Cleveland

University of California, San Diego, USA

Rosa Rademakers

Rosa Rademakers

VIB Center for Molecular Neurology, Antwerp, Belgium

Ler mais sobre Rosa Rademakers

Session 5: Structural insights into pathological RNA-binding proteins

MP

Magdalini Polymenidou

University of Zürich, Switzerland

Ben Ryskeldi-Falcon

Ben Ryskeldi-Falcon

MRC Cambridge, UK

Ler mais sobre Ben Ryskeldi-Falcon

Session 6: Toxicity of repeat RNAs and repeat proteins

DE

Dieter Edbauer

German Center for Neurodegenerative Diseases, Munich, Germany

LR

Laura Ranum

University of Florida, Gainesville, USA

Session 7: Novel biomarkers due to dysregulated RNA metabolism

MW

Michael Ward

National Institutes of Health, USA

Philip Wong

Philip Wong

Johns Hopkins University, USA

Ler mais sobre Philip Wong

Session 8: RNA-based therapeutics

AK

Anastasia Khvorova

University of Massachusetts Chan Medical School, USA

MS

Matthew Simon

Denali Therapeutics, USA

Discussion leaders

Session 1: Benjamin Wolozin, Boston University, USA Session 2: Albert La Spada, University of California Irvine, USA Session 3: Yi Lin, Tsinghua University, Beijing, China Session 4: Nancy Bonini, University of Pennsylvania, USA Session 5: Lin Guo, Thomas Jefferson University, USA Session 6: Jeffrey Rothstein, Johns Hopkins University, USA Session 7: Leonard Petrucelli, Mayo Clinic, USA Session 8: Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany